Key result
Machine learning model predicts depression risk in hypertensive patients with ~0.76 AUC.
Why the study?
Validated, hypertension-specific depression screening tools based on machine learning are lacking despite a high prevalence of comorbid depression.
Does a machine learning-based screening tool accurately predict depression risk in adult hypertensive patients?
Cross-Sectional (n=6,687)
Does a machine learning-based screening tool accurately predict depression risk in adult hypertensive patients?
A novel random forest-based machine learning tool using 12 predictors can effectively assess depression risk in adult hypertensive patients, facilitating early intervention.
Answers are grounded in this paper and cite their sources.
May support depression screening in hypertensive patients; leaves open prospective validation before clinical adoption.
Hypertension and depression have a well-recognized bidirectional association, with comorbidity reducing antihypertensive medication adherence and elevating adverse health outcomes; depression affects 30% to 40% of hypertensive patients, far higher than the general population. However, validated, hypertension-specific depression screening tools based on machine learning (ML) are currently lacking. This study aimed to develop, validate, and visualize an ML-based depression screening tool for adult hypertensive patients. A cross-sectional study was conducted using 2005-2020 National Health and Nutrition Examination Survey data of 6687 hypertensive patients aged ≥20 years (depression defined by Patient Health Questionnaire-9 score ≥ 10). Least absolute shrinkage and selection operator regression was used for feature selection, data were split into a 7:3 training/test set, and 7 ML models were constructed. Model performance was assessed by area under the receiver operating characteristic curve, calibration, and clinical utility (decision curve analysis); SHapley Additive exPlanations values ensured interpretability, and a web-based tool was built from the optimal model. The random forest model was identified as the optimal screening tool (area under the receiver operating characteristic curve = 0.761), with good calibration and favorable net clinical benefit (threshold probability: 0.07-0.39). Twelve key predictors were established, with sleep disturbances as the top factor, followed by poverty-to-income ratio and age. An interactive online screening tool (https://chunyuzhang28.shinyapps.io/Hypertension/) was developed, enabling rapid depression risk prediction for hypertensive patients via input of the 12 predictors. This random forest-based ML screening tool is a valid and practical tool for clinical depression risk assessment in adult hypertensive patients. Clinicians can use it to stratify depression risk in hypertensive patients, identify high-risk subgroups (e.g., those with sleep disturbances or low poverty-to-income ratio), and implement targeted early intervention and integrated management strategies for hypertension and depression, thus optimizing clinical decision-making for comorbidity care.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2026) conducted a cross-sectional in Hypertension (n=6,687). Random forest machine learning screening tool was evaluated on Model performance (area under the receiver operating characteristic curve) (AUC 0.761). A random forest machine learning model successfully predicted depression risk in adult hypertensive patients with an area under the receiver operating characteristic curve of 0.761.
Synapse has enriched 10 related papers. Consider them for comparative context: